Roberts holds a Bachelor of Science in Accounting and Finance, magna cum laude, from Boston College and is a Certified Public Accountant.

“I am pleased to announce that Carsten Boess will lead our international initiatives,” said Duane DeSisto, president and chief executive officer of Insulet. “In his thirteen years at Novo Nordisk, Carsten served in several strategic financial and operational roles in Europe, Asia, North America and South America. His extensive experience abroad, particularly in the European diabetes market, makes him uniquely qualified for this critical role.”

DeSisto added, “We are fortunate to welcome Brian Roberts as Insulet’s new CFO. Brian brings proven leadership in strategic planning and building strong financial operations for high-growth companies. His track record as a financial executive focused on working capital and profitability will be a tremendous asset to Insulet as we continue to grow.”